The drug beating Ozempic, Pimp my Portfolio with Luke Laretive & Australia's most popular small caps
<p>From Ozempic’s soaring popularity to the top small-cap stocks held by Australia’s best managers, this episode dives into the trends shaping markets today. Plus, Luke Laretive unpacks Blair's portfolio, exploring the growing interest in private equity and whether retail investors can get a slice of the action.</p><br><p>Calling all Financial Advisers! We're hosting the inaugural Basis Points Boat Party on Sydney Harbour on March 13th – 200 advisers, fresh insights, and a lot of fun.</p><p>Tickets are complimentary, but limited and exclusive …
N'eo ket bet treuzskrivet an taol-mañ c'hoazh
Arverañ STT.ai evit treiñ an taol-kaoz-mañ gant AI. Degas skrid a-feson gant dizoleiñ ar c'haozeerien, ar stampoù amzer, hag ezporzhiañ e meur a mentrezh.